Please use this identifier to cite or link to this item:
|Title:||Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein||Authors:||Lu, L.
|Issue Date:||2006||Citation:||Lu, L., Ho, Y., Kwang, J. (2006). Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochemical and Biophysical Research Communications 340 (4) : 1178-1183. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbrc.2005.12.133||Abstract:||The ability to synthesize shRNAs from DNA templates driven by RNA polymerase III promoters has made it possible to apply virus-derived vectors as delivery vehicles for double-strand RNA-mediated interference. Baculovirus emerges as a promising vector for in vivo gene therapy most recently. To investigate its potential as a delivery vector for anti-virus shRNA targeting arterivirus porcine reproductive and respiratory syndrome virus (PRRSV), we constructed recombinant baculovirus vectors bearing a shRNA-synthesizing cassette driven by U6 promoter with enhanced transduction efficiency by displaying vesicular stomatitis virus glycoprotein on viral envelope. Transduction of Marc145 cells with a recombinant baculovirus delivering egfp gene-specific shRNA dramatically suppressed the expression of EGFP in this cell line; and transduction of Marc145 cells with a baculovirus delivering shRNA specific for the C-terminal nucleoprotein coding region of PRRSV genome resulted in inhibition of viral replication. Our data highlight the recombinant baculovirus as an alternative vehicle for anti-virus shRNA delivery. © 2005 Elsevier Inc. All rights reserved.||Source Title:||Biochemical and Biophysical Research Communications||URI:||http://scholarbank.nus.edu.sg/handle/10635/24751||ISSN:||0006291X
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 10, 2019
WEB OF SCIENCETM
checked on Dec 3, 2019
checked on Dec 2, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.